Company Filing History:
Years Active: 2009-2022
Title: Matthias Schwab: Innovator in Tissue Cultivation Technology
Introduction
Matthias Schwab is a notable inventor based in Stuttgart, Germany. He has made significant contributions to the field of medical technology, particularly in the area of tissue cultivation. With a total of 4 patents to his name, Schwab's work focuses on innovative methods and devices that enhance the testing of active ingredients and medications.
Latest Patents
One of Schwab's latest patents is a device for cultivating tissue sections. This device is designed specifically for testing active ingredients and medications. It includes a frame, at least one carrier component to hold a tissue section, and a liquid-absorbing strip element. The cultivation system comprises this device along with a holding vessel, allowing for effective testing on tissue sections. Another significant patent involves a cell selection method that enables the in vitro selection of therapeutic cell subpopulations from an original population of eukaryotic cells. This method is particularly useful for treating diseases affecting tissues or organs, as it focuses on selecting highly migrative cell subpopulations.
Career Highlights
Throughout his career, Matthias Schwab has worked with esteemed institutions such as Eberhard Karls Universität Tübingen Medizinische Fakultät and Robert Bosch Gesellschaft für Medizinische Forschung GmbH. His work in these organizations has contributed to advancements in medical research and technology.
Collaborations
Schwab has collaborated with notable colleagues, including Lusine Danielyan and Christoph Gleiter. These partnerships have further enriched his research and development efforts in the field of tissue cultivation.
Conclusion
Matthias Schwab's innovative contributions to tissue cultivation technology highlight his role as a key inventor in the medical field. His patents and collaborations reflect a commitment to advancing healthcare solutions through scientific research and innovation.